Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias
Data de publicação: 21/03/2022 - 17:54
The war in Ukraine has been thoroughly divulged, discussed, and explained on all social media platforms, in Brazil and abroad. Its geopolitical, economic, and social consequences have also been explored by specialists of all fields of knowledge and geographical position. However, there is one dimension that has been left out by this widely encompassing debate: the matter of health.
On the other hand, more attentive readers will certainly not...
Notícias
Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately.
The drugs studied are already...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases.
In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias
Data de publicação: 16/03/2022 - 11:20
Through the Institute of Drug Technology (Farmanguinhos) and French laboratory Servier, Fiocruz signed, last Thursday (March 10th), a Memorandum of Understanding for technical cooperation to develop new drugs against chronic diseases, from a new pharmaceutical platform. This is an innovative technology based on the prolonged release of the active ingredient in the body, resulting in efficacy, safety, and more compliance and practicality for...
Notícias
Data de publicação: 30/03/2022 - 10:15
In a meeting promoted on March 28, by the Center for International Relations in Health (Cris/Fiocruz) and the Vice-Presidencies of Research and Biological Collections (VPPCB) and Education, Information and Communication (VPEIC), members of the Consulate General of the United States in Rio de Janeiro continued the partnership process initiated in 2021. The aim is to expand scientific cooperation between Fiocruz and American institutions....
Notícias
Data de publicação: 09/02/2022 - 17:07
A study analyzed the geographic distribution and the incidence of co-infection with a human T-lymphotropic virus (HTLV) and a human immunodeficiency virus (HIV) in Bahia, which is an endemic state for both retroviruses. The research was carried out using all samples submitted to serological tests at the Central Public Health Laboratory of Bahia (Lacen-BA), from 2004 to 2013. The total was about 130,000 samples from 358 of the 417 municipalities...
Notícias
Data de publicação: 14/12/2021 - 17:24
In a pioneering initiative, the Foundation inaugurates this Monday (13/12), COVID-19 Biobank (BC19-Fiocruz). Located in Rio de Janeiro, at Expansão campus, BC19-Fiocruz will enable the design and conduct of research, technological development and clinical trials related to COVID-19, regardless of the geographic location of human biological material and viruses. With the capacity to store up to one and a half million samples of human and...
Notícias
Data de publicação: 06/12/2021 - 14:57
The Oswaldo Cruz Foundation, by means of the Fio-Schisto, the Translational Research Program in Schistosomiasis, informs that researcher Otávio Pieri, of the Oswaldo Cruz Institute (IOC), was invited to become part of the World Health Organization (WHO) group on schistosomiasis and helminth diseases transmitted through the soil (geo helminth diseases). Fio-Schisto is bound to the Vice-Presidency of Biological Research and Collections....
Notícias
Data de publicação: 10/12/2021 - 13:11
Fifteen years after visiting Fiocruz as a tourist, Pietro Lazzeri returned to the Foundation on Tuesday (12/07), this time as Switzerland ambassador. In office for six months, he met with Fiocruz members at the Fiocruz Global Health Center (CRIS/Fiocruz), where he proposed to expand technical and scientific cooperation. He also visited Bio-Manguinhos, where he found out that some of the machines used in the production of the COVID-19 vaccine...
Notícias
Data de publicação: 14/12/2021 - 16:48
A research published today by The Lancet - one of the most prestigious scientific journals focused on the medical field in the world - brought together experts to explain how the economic downturn will affect for years and will be worse in developing countries. Without a consensus for preventive action, families and communities will be disproportionately affected. In the long run, inequalities in health, physical and...
Notícias
Data de publicação: 23/12/2021 - 09:52
The ties between Fiocruz and the United States Consulate in Rio de Janeiro should become closer next year. On 12/16, the consul Jacqueline Ward and the president of Fiocruz, Nísia Trindade Lima, met at the Official Residence. On the agenda, scientific cooperation between Brazilian and American institutions, the XVI National Malaria Research Meeting and a parallel symposium organized by the Foundation and the National Institute of Allergy...
Notícias
Data de publicação: 04/01/2022 - 15:30
A study published on medRXiv, this Wednesday (December 29th), shows that the four vaccines applied in Brazil provide a high degree of additional protection against symptomatic infections and severe cases of COVID-19 in people who had already contracted Sars-CoV-2 previously. The study, led by Julio Croda and Manoel Barral-Neto, Fiocruz researchers, also reinforces the importance of a full vaccination scheme, even for those people.
Vaccine...
Notícias
Data de publicação: 10/01/2022 - 14:43
This Friday (January 7), Fiocruz received assent from the National Agency of Sanitary Surveillance (Anvisa) for the alteration in the register of the COVID-19 vaccine (recombinant), which requested the addition of the Foundation as a producer of the Active Pharmaceutical Ingredient (API). After the transference of the AstraZeneca technology and with the approval of Anvisa, the Foundation is now the first institution in the country that is...
Notícias
Data de publicação: 19/01/2022 - 17:26
Science, technology and innovation to create resiliency, recover the planet from the impacts of COVID-19 and prepare it to face future health crises, including the ones resulting from environmental problems. This was the focus of the Global Sustainable Technology and Inovation Conference (G-Stic), an international reference in the debate that relates science, technology and innovation to the 2030 Agenda, which took place in Dubai from January...
Notícias
Data de publicação: 19/01/2022 - 17:49
We all had some degree of hope that the end of 2021 and the beginning of 2022 would bring us the much-awaited retraction of the pandemic. However, the emergence of the new Omicron variant dragged us away from the end of the tunnel we were longing for. Many countries, including some with powerful health systems, excellent living conditions, and high levels of vaccination, are hitting record numbers of contagions every day.
So far, the...
Notícias
Data de publicação: 03/11/2021 - 11:51
Last Thursday (28 October) Fiocruz signed, during a ceremony that took place at the headquarters of AstraZeneca, in Cambridge, United Kingdom, a joint declaration of commitment for the acquisition of Active Pharmaceutical Ingredient (API) with the goal of producing 60 million doses of the COVID-19 vaccine (recombinant) in order to make up the deliveries of the Foundation for 2022. The commitment signed by the institutions aims to guarantee wide...
Notícias
Data de publicação: 22/11/2021 - 13:51
With two actions this week, Fiocruz became even more engaged in the fight against Hansen's, a neglected disease that had its situation aggravated during the COVID-19 pandemic. On Wednesday (11/17), the Foundation signed a Cooperation Agreement for joining the global campaign Don't Forget Hansen's Disease, with the state government and other partners, in addition to lighting the castle with purple at night as one of the actions to...
Notícias
Data de publicação: 16/10/2021 - 17:55
Sociologist and Fiocruz president, Nísia Trindade Lima, presented last Friday (October 8th) the conference Pandemic and Social Inequalities: Challenges for Global Health. The event was part of the Global Health Colloquium Series, a biannual series of lectures by Princeton University's Program in Global Health. Nísia thanked the university and Brazil Lab for the invitation, a hub that connects researchers and professors...
Notícias
Data de publicação: 30/11/2021 - 12:23
Last Thursday (25 November) the Oswaldo Cruz Foundation, by means of its Immunobiological Technology Institute (Bio-Manguinhos/Fiocruz), submitted to the Brazilian Health Regulatory Agency (Anvisa) a request of post-registration alteration of its COVID-19 vaccine (recombinant), asking to include the Institute as the manufacturing unit of the Active Pharmaceutical Ingredient (API). Check out this 360º view of the production area for the...
Notícias
Data de publicação: 22/10/2021 - 09:48
Would it be possible to establish a new food model without the large producers' participation? Finding this answer is an ongoing global challenge and resounded in the seminar Food security, health and pandemics in United Nations events, organized by the Fiocruz Global Health Center (CRIS/Fiocruz). Divergent analyses and opinions revealed behind the scenes of international decisions on hunger programs and inspired empathy in provocative,...
Notícias
Data de publicação: 07/10/2021 - 14:50
In the first decades of the twentieth century, the American multinational United Fruit Company, prominent in the production and sale of tropical fruits, found a way to deal with malnutrition among its workers in Costa Rica: it imported canned and processed foods from the United States. At the same time, the solution to high infant mortality in the banana plantation zone was the introduction of an artificial food developed by Nestlé. Years...
Notícias
Data de publicação: 29/11/2021 - 10:28
Severe cases of COVID-19 are related to the ageing of the immune system and to acute immunodeficiency. It is what the new study led by the Oswaldo Cruz Institute (IOC/Fiocruz) and by the Federal University of Rio de Janeiro (UFRJ) shows, published in the academic journal Journal of Infectious Diseases.
By analyzing blood samples of patients that have been hospitalized with the disease, the researchers detected signs of hyperactivity,...
Notícias
Data de publicação: 20/10/2021 - 10:49
A cooperation that dates back to the beginning of the last century and that has been renovated and expanded over the decades was celebrated last Thursday (October 14th), with the visit of Portugal’s assistant secretary of Health, António Lacerda Sales, to Fiocruz. Accompanied by the Secretary of State of the Portuguese Communities, Berta Nunes, and by ambassador Luís Faro Ramos, among other members of the delegation, Sales...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
